title: Use of a BRCA1 peptide validates MS110 as a BRCA1-specific antibody in immunohistochemistry.
authors.forename: A
authors.initials: A
authors.lastname: Alamshah
authors.forename: R
authors.initials: R
authors.lastname: Springall
authors.forename: C E
authors.initials: CE
authors.lastname: Gillett
authors.forename: E
authors.initials: E
authors.lastname: Solomon
authors.forename: J R
authors.initials: JR
authors.lastname: Morris
mesh_terms: D019138:Antibodies, Blocking / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000276:immunology; D000918:Antibody Specificity; D019313:BRCA1 Protein / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000276:immunology / Q000378:metabolism*; D001940:Breast / Q000378:metabolism* / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry
chemical_list: D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D014408:Biomarkers, Tumor